Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke

Inflammation following ischemic brain injury is correlated with adverse outcome. Preclinical studies indicate that treatment with acetylsalicylic acid + extended-release dipyridamole (ASA + ER-DP) has anti-inflammatory and thereby neuroprotective effects by inhibition of monocyte chemotactic protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Worthmann, Hans, Dengler, Reinhard, Schumacher, Helmut, Schwartz, Andreas, Eisert, Wolfgang G., Lichtinghagen, Ralf, Weissenborn, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430258/
https://www.ncbi.nlm.nih.gov/pubmed/22942727
http://dx.doi.org/10.3390/ijms13078670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430258/
https://www.ncbi.nlm.nih.gov/pubmed/22942727
http://dx.doi.org/10.3390/ijms13078670

Ejemplares similares